nach oben

Erschienen in:

01.08.2019 | Autoimmunity (TK Tarrant, Section Editor)

Laser Light Therapy in Inflammatory, Musculoskeletal, and Autoimmune Disease

verfasst von: Victoria A. Wickenheisser, Emilia Marta Zywot, Emily Mary Rabjohns, Hyun Ho Lee, David S. Lawrence, Teresa Kathleen Tarrant

Erschienen in: Current Allergy and Asthma Reports | Ausgabe 8/2019

Einloggen, um Zugang zu erhalten

Abstract

Purpose of Review

The goal of this review is to summarize the field to date and to discuss strengths and limitations of low-level laser (light) therapy (LLLT) for the future investigation as a treatment of inflammatory disease.

Recent Findings

LLLT is a promising therapeutic, particularly for those diseases of skin and joints because they are most accessible to treatment. Indeed, the known mechanisms of LLLT support its use for anti-inflammatory purposes, as well as stimulation of tissue growth and repair. Although the standard of care for the majority of inflammatory diseases is immunosuppressive agents such as corticosteroids with undesirable toxicities, LLLT offers a unique approach by being non-invasive and incurring minimal side effects. It is also relatively inexpensive and accessible and even has the possibility to be patient directed at home.

Summary

There is evidence that LLLT is able to modulate the immune system at the skin and joint, and it has been shown to be efficacious in humans by affecting bacterial colonization as it may pertain to chronic rhinosinusitis. However, there is variability in the methods of laser application as well as a lack of evidence for laser type, dose-ranging studies, and wavelength selection that create barriers to the implementation of LLLT without further more rigorous and standardized study. The heterogeneity makes it difficult to draw strong conclusions about the efficacy of LLLT and its mechanisms.

•• Chung H, Dai T, Sharma SK, Huang YY, Carroll JD, Hamblin MR. The nuts and bolts of low-level laser (light) therapy. Ann Biomed Eng. 2012;40(2):516–33 https://doi.org/10.1007/s10439-011-0454-7. This provides foundational knowledge on the components and evolution of LLLT. CrossRef

•• de Freitas LF, Hamblin MR. Proposed mechanisms of photobiomodulation or low-level light therapy. IEEE J Sel Top Quantum Electron. 2016;22(3). Doi:https://doi.org/10.1109/JSTQE.2016.2561201. This study summarizes the current proposed mechanisms of LLLT. CrossRef

Lupton JR, Alster TS. Laser scar revision. Dermatol Clin. 2002;20(1):55–65.CrossRef

Felsher DW. Cancer revoked: oncogenes as therapeutic targets. Nat Rev Cancer. 2003;3(5):375–80. https://doi.org/10.1038/nrc1070.CrossRefPubMed

Karu TI. Multiple roles of cytochrome c oxidase in mammalian cells under action of red and IR-A radiation. IUBMB Life. 2010;62(8):607–10. https://doi.org/10.1002/iub.359.CrossRefPubMed

Poyton RO, Ball KA. Therapeutic photobiomodulation: nitric oxide and a novel function of mitochondrial cytochrome c oxidase. Discov Med. 2011;11(57):154–9.PubMed

Chen AC, Arany PR, Huang YY, Tomkinson EM, Sharma SK, Kharkwal GB, et al. Low-level laser therapy activates NF-kB via generation of reactive oxygen species in mouse embryonic fibroblasts. PLoS One. 2011;6(7):e22453. https://doi.org/10.1371/journal.pone.0022453.CrossRefPubMedPubMedCentral

Gao X, Xing D. Molecular mechanisms of cell proliferation induced by low power laser irradiation. J Biomed Sci. 2009;16:4. https://doi.org/10.1186/1423-0127-16-4.CrossRefPubMedPubMedCentral

Nesioonpour S, Mokmeli S, Vojdani S, Mohtadi A, Akhondzadeh R, Behaeen K, et al. The effect of low-level laser on postoperative pain after tibial fracture surgery: a double-blind controlled randomized clinical trial. Anesth Pain Med. 2014;4(3):e17350. https://doi.org/10.5812/aapm.17350.CrossRefPubMedPubMedCentral

10.

Falaki F, Nejat AH, Dalirsani Z. The effect of low-level laser therapy on trigeminal neuralgia: a review of literature. J Dent Res Dent Clin Dent Prospects. 2014;8(1):1–5. https://doi.org/10.5681/joddd.2014.001.CrossRefPubMedPubMedCentral

11.

Cotler HB, Chow RT, Hamblin MR, Carroll J. The use of low level laser therapy (LLLT) for musculoskeletal pain. MOJ Orthop Rheumatol. 2015;2(5). https://doi.org/10.15406/mojor.2015.02.00068.

12.

Bashiri H. Evaluation of low level laser therapy in reducing diabetic polyneuropathy related pain and sensorimotor disorders. Acta Med Iran. 2013;51(8):543–7.PubMed

13.

Chow RT, David MA, Armati PJ. 830 nm laser irradiation induces varicosity formation, reduces mitochondrial membrane potential and blocks fast axonal flow in small and medium diameter rat dorsal root ganglion neurons: implications for the analgesic effects of 830 nm laser. J Peripher Nerv Syst. 2007;12(1):28–39. https://doi.org/10.1111/j.1529-8027.2007.00114.x.CrossRefPubMed

14.

Carati CJ, Anderson SN, Gannon BJ, Piller NB. Treatment of postmastectomy lymphedema with low-level laser therapy: a double blind, placebo-controlled trial. Cancer. 2003;98(6):1114–22. https://doi.org/10.1002/cncr.11641.CrossRefPubMed

15.

Klein T, Magerl W, Hopf HC, Sandkuhler J, Treede RD. Perceptual correlates of nociceptive long-term potentiation and long-term depression in humans. J Neurosci. 2004;24(4):964–71. https://doi.org/10.1523/JNEUROSCI.1222-03.2004.CrossRefPubMed

16.

Hagiwara S, Iwasaka H, Okuda K, Noguchi T. GaAlAs (830 nm) low-level laser enhances peripheral endogenous opioid analgesia in rats. Lasers Surg Med. 2007;39(10):797–802. https://doi.org/10.1002/lsm.20583.CrossRefPubMed

17.

Dima R, Tieppo Francio V, Towery C, Davani S. Review of literature on low-level laser therapy benefits for nonpharmacological pain control in chronic pain and osteoarthritis. Altern Ther Health Med. 2017.

18.

Clijsen R, Brunner A, Barbero M, Clarys P, Taeymans J. Effects of low-level laser therapy on pain in patients with musculoskeletal disorders: a systematic review and meta-analysis. Eur J Phys Rehabil Med. 2017;53(4):603–10. https://doi.org/10.23736/S1973-9087.17.04432-X.CrossRefPubMed

19.

Todd KH, Funk JP. The minimum clinically important difference in physician-assigned visual analog pain scores. Acad Emerg Med. 1996;3(2):142–6.CrossRef

20.

Gallagher EJ, Bijur PE, Latimer C, Silver W. Reliability and validity of a visual analog scale for acute abdominal pain in the ED. Am J Emerg Med. 2002;20(4):287–90.CrossRef

21.

Rochkind S, Drory V, Alon M, Nissan M, Ouaknine GE. Laser phototherapy (780 nm), a new modality in treatment of long-term incomplete peripheral nerve injury: a randomized double-blind placebo-controlled study. Photomed Laser Surg. 2007;25(5):436–42. https://doi.org/10.1089/pho.2007.2093.CrossRefPubMed

22.

Lazovic M, Ilic-Stojanovic O, Kocic M, Zivkovic V, Hrkovic M, Radosavljevic N. Placebo-controlled investigation of low-level laser therapy to treat carpal tunnel syndrome. Photomed Laser Surg. 2014;32(6):336–44. https://doi.org/10.1089/pho.2013.3563.CrossRefPubMed

23.

Bekhet AH, Ragab B, Abushouk AI, Elgebaly A, Ali OI. Efficacy of low-level laser therapy in carpal tunnel syndrome management: a systematic review and meta-analysis. Lasers Med Sci. 2017;32(6):1439–48. https://doi.org/10.1007/s10103-017-2234-6.CrossRefPubMed

24.

Majithia V, Geraci SA. Rheumatoid arthritis: diagnosis and management. Am J Med. 2007;120(11):936–9. https://doi.org/10.1016/j.amjmed.2007.04.005.CrossRefPubMed

25.

Alves AC, de Carvalho PT, Parente M, Xavier M, Frigo L, Aimbire F, et al. Low-level laser therapy in different stages of rheumatoid arthritis: a histological study. Lasers Med Sci. 2013;28(2):529–36. https://doi.org/10.1007/s10103-012-1102-7.CrossRefPubMed

26.

Sasai M, Saeki Y, Ohshima S, Nishioka K, Mima T, Tanaka T, et al. Delayed onset and reduced severity of collagen-induced arthritis in interleukin-6-deficient mice. Arthritis Rheum. 1999;42(8):1635–43. https://doi.org/10.1002/1529-0131(199908)42:8<1635::AID-ANR11>3.0.CO;2-Q.CrossRefPubMed

27.

Sack U, Kinne RW, Marx T, Heppt P, Bender S, Emmrich F. Interleukin-6 in synovial fluid is closely associated with chronic synovitis in rheumatoid arthritis. Rheumatol Int. 1993;13(2):45–51.CrossRef

28.

Madhok R, Crilly A, Watson J, Capell HA. Serum interleukin 6 levels in rheumatoid arthritis: correlations with clinical and laboratory indices of disease activity. Ann Rheum Dis. 1993;52(3):232–4. https://doi.org/10.1136/ard.52.3.232.CrossRefPubMedPubMedCentral

29.

Gomez-Reino JJ, Carmona L, Group B. Switching TNF antagonists in patients with chronic arthritis: an observational study of 488 patients over a four-year period. Arthritis Res Ther. 2006;8(1):R29. https://doi.org/10.1186/ar1881.CrossRefPubMedPubMedCentral

30.

Hyrich KL, Lunt M, Watson KD, Symmons DP, Silman AJ, British Society for Rheumatology Biologics R. Outcomes after switching from one anti-tumor necrosis factor alpha agent to a second anti-tumor necrosis factor alpha agent in patients with rheumatoid arthritis: results from a large UK national cohort study. Arthritis Rheum 2007;56(1):13–20. doi:https://doi.org/10.1002/art.22331.CrossRef

31.

Nuki G, Bresnihan B, Bear MB, McCabe D, European Group Of Clinical I. Long-term safety and maintenance of clinical improvement following treatment with anakinra (recombinant human interleukin-1 receptor antagonist) in patients with rheumatoid arthritis: extension phase of a randomized, double-blind, placebo-controlled trial. Arthritis Rheum 2002;46(11):2838–2846. doi:https://doi.org/10.1002/art.10578.CrossRef

32.

Serafin DS, Allyn B, Sassano MF, Timoshchenko RG, Mattox D, Brozowski JM, et al. Chemerin-activated functions of CMKLR1 are regulated by G protein-coupled receptor kinase 6 (GRK6) and beta-arrestin 2 in inflammatory macrophages. Mol Immunol. 2019;106:12–21. https://doi.org/10.1016/j.molimm.2018.12.016.CrossRefPubMed

33.

Tarrant TK, Patel DD. Chemokines and leukocyte trafficking in rheumatoid arthritis. Pathophysiology. 2006;13(1):1–14. https://doi.org/10.1016/j.pathophys.2005.11.001.CrossRefPubMed

34.

Zhang L, Zhao J, Kuboyama N, Abiko Y. Low-level laser irradiation treatment reduces CCL2 expression in rat rheumatoid synovia via a chemokine signaling pathway. Lasers Med Sci. 2011;26(5):707–17. https://doi.org/10.1007/s10103-011-0917-y.CrossRefPubMed

35.

Avci P, Gupta A, Sadasivam M, Vecchio D, Pam Z, Pam N, et al. Low-level laser (light) therapy (LLLT) in skin: stimulating, healing, restoring. Semin Cutan Med Surg. 2013;32(1):41–52.PubMedPubMedCentral

36.

Lee SY, You CE, Park MY. Blue and red light combination LED phototherapy for acne vulgaris in patients with skin phototype IV. Lasers Surg Med. 2007;39(2):180–8. https://doi.org/10.1002/lsm.20412.CrossRefPubMed

37.

Ross EV. Optical treatments for acne. Dermatol Ther. 2005;18(3):253–66. https://doi.org/10.1111/j.1529-8019.2005.05024.x.CrossRefPubMed

38.

Rotunda AM, Bhupathy AR, Rohrer TE. The new age of acne therapy: light, lasers, and radiofrequency. J Cosmet Laser Ther. 2004;6(4):191–200. https://doi.org/10.1080/14764170410008124.CrossRefPubMed

39.

Sadick NS. Handheld LED array device in the treatment of acne vulgaris. J Drugs Dermatol. 2008;7(4):347–50.PubMed

40.

• Omi T, Kawana S, Sato S, Takezaki S, Honda M, Igarashi T, et al. Cutaneous immunological activation elicited by a low-fluence pulsed dye laser. Br J Dermatol. 2005;153(Suppl 2):57–62. https://doi.org/10.1111/j.1365-2133.2005.06971.x This study describes the changes induced by LLLT in healthy human skin and supports its immunomodulatory effects. CrossRef

41.

Greb JE, Goldminz AM, Elder JT, Lebwohl MG, Gladman DD, Wu JJ, et al. Psoriasis. Nat Rev Dis Primers. 2016;2:16082. https://doi.org/10.1038/nrdp.2016.82.CrossRefPubMed

42.

Zhang P, Wu MX. A clinical review of phototherapy for psoriasis. Lasers Med Sci. 2018;33(1):173–80. https://doi.org/10.1007/s10103-017-2360-1.CrossRefPubMed

43.

Tartar D, Bhutani T, Huynh M, Berger T, Koo J. Update on the immunological mechanism of action behind phototherapy. J Drugs Dermatol. 2014;13(5):564–8.PubMed

44.

Pittelkow MR, Perry HO, Muller SA, Maughan WZ, O'Brien PC. Skin cancer in patients with psoriasis treated with coal tar. A 25-year follow-up study. Arch Dermatol. 1981;117(8):465–8.CrossRef

45.

Stern RS, Study PF-U. The risk of squamous cell and basal cell cancer associated with psoralen and ultraviolet A therapy: a 30-year prospective study. J Am Acad Dermatol. 2012;66(4):553–62. https://doi.org/10.1016/j.jaad.2011.04.004.CrossRefPubMed

46.

Stern RS, Study PF. The risk of melanoma in association with long-term exposure to PUVA. J Am Acad Dermatol. 2001;44(5):755–61. https://doi.org/10.1067/mjd.2001.114576.CrossRefPubMed

47.

Ablon G. Combination 830-nm and 633-nm light-emitting diode phototherapy shows promise in the treatment of recalcitrant psoriasis: preliminary findings. Photomed Laser Surg. 2010;28(1):141–6. https://doi.org/10.1089/pho.2009.2484.CrossRefPubMed

48.

Weinstabl A, Hoff-Lesch S, Merk HF, von Felbert V. Prospective randomized study on the efficacy of blue light in the treatment of psoriasis vulgaris. Dermatology. 2011;223(3):251–9. https://doi.org/10.1159/000333364.CrossRefPubMed

49.

Bernardez C, Molina-Ruiz AM, Requena L. Histologic features of alopecias-part I: nonscarring alopecias. Actas Dermosifiliogr. 2015;106(3):158–67. https://doi.org/10.1016/j.ad.2014.07.006.CrossRefPubMed

50.

Tzung TY, Chen CY, Tzung TY, Kao FJ, Chen WC. Infrared irradiation as an adjuvant therapy in recalcitrant alopecia areata. Dermatol Surg. 2009;35(4):721–3. https://doi.org/10.1111/j.1524-4725.2009.01120.x.CrossRefPubMed

51.

Yoo KH, Kim MN, Kim BJ, Kim CW. Treatment of alopecia areata with fractional photothermolysis laser. Int J Dermatol. 2010;49(7):845–7. https://doi.org/10.1111/j.1365-4632.2009.04230.x.CrossRefPubMed

52.

Lanzafame RJ, Blanche RR, Chiacchierini RP, Kazmirek ER, Sklar JA. The growth of human scalp hair in females using visible red light laser and LED sources. Lasers Surg Med. 2014;46(8):601–7. https://doi.org/10.1002/lsm.22277.CrossRefPubMed

53.

Mlacker S, Aldahan AS, Simmons BJ, Shah V, McNamara CA, Samarkandy S, et al. A review on laser and light-based therapies for alopecia areata. J Cosmet Laser Ther. 2017;19(2):93–9. https://doi.org/10.1080/14764172.2016.1248440.CrossRefPubMed

54.

Darwin E, Arora H, Hirt PA, Wikramanayake TC, Jimenez JJ. A review of monochromatic light devices for the treatment of alopecia areata. Lasers Med Sci. 2018;33(2):435–44. https://doi.org/10.1007/s10103-017-2412-6.CrossRefPubMed

55.

Mester E, Szende B, Gartner P. The effect of laser beams on the growth of hair in mice. Radiobiol Radiother (Berl). 1968;9(5):621–6.

56.

Lolis MS, Marmur ES. Paradoxical effects of hair removal systems: a review. J Cosmet Dermatol. 2006;5(4):274–6. https://doi.org/10.1111/j.1473-2165.2006.00269.x.CrossRefPubMed

57.

Waiz M, Saleh AZ, Hayani R, Jubory SO. Use of the pulsed infrared diode laser (904 nm) in the treatment of alopecia areata. J Cosmet Laser Ther. 2006;8(1):27–30. https://doi.org/10.1080/14764170600607368.CrossRefPubMed

58.

Yamazaki M, Miura Y, Tsuboi R, Ogawa H. Linear polarized infrared irradiation using Super Lizer is an effective treatment for multiple-type alopecia areata. Int J Dermatol. 2003;42(9):738–40.CrossRef

59.

Simon D, Braathen LR, Simon HU. Eosinophils and atopic dermatitis. Allergy. 2004;59(6):561–70. https://doi.org/10.1111/j.1398-9995.2004.00476.x.CrossRefPubMed

60.

Stich AN, Rosenkrantz WS, Griffin CE. Clinical efficacy of low-level laser therapy on localized canine atopic dermatitis severity score and localized pruritic visual analog score in pedal pruritus due to canine atopic dermatitis. Vet Dermatol. 2014;25(5):464–e74. https://doi.org/10.1111/vde.12144.CrossRefPubMed

61.

Conzemius MG, Evans RB. Caregiver placebo effect for dogs with lameness from osteoarthritis. J Am Vet Med Assoc. 2012;241(10):1314–9. https://doi.org/10.2460/javma.241.10.1314.CrossRefPubMed

62.

Perl TM, Cullen JJ, Wenzel RP, Zimmerman MB, Pfaller MA, Sheppard D, et al. Intranasal mupirocin to prevent postoperative Staphylococcus aureus infections. N Engl J Med. 2002;346(24):1871–7. https://doi.org/10.1056/NEJMoa003069.CrossRefPubMed

63.

Bode LG, Kluytmans JA, Wertheim HF, Bogaers D, Vandenbroucke-Grauls CM, Roosendaal R, et al. Preventing surgical-site infections in nasal carriers of Staphylococcus aureus. N Engl J Med. 2010;362(1):9–17. https://doi.org/10.1056/NEJMoa0808939.CrossRefPubMed

64.

Krespi YP, Kizhner V. Laser-assisted nasal decolonization of Staphylococcus aureus, including methicillin-resistant Staphylococcus aureus. Am J Otolaryngol. 2012;33(5):572–5. https://doi.org/10.1016/j.amjoto.2012.02.002.CrossRefPubMed

65.

Benninger MS, Ferguson BJ, Hadley JA, Hamilos DL, Jacobs M, Kennedy DW, et al. Adult chronic rhinosinusitis: definitions, diagnosis, epidemiology, and pathophysiology. Otolaryngol Head Neck Surg. 2003;129(3 Suppl):S1–32.CrossRef

66.

Harvey RJ, Lund VJ. Biofilms and chronic rhinosinusitis: systematic review of evidence, current concepts and directions for research. Rhinology. 2007;45(1):3–13.PubMed

67.

Kariyawasam HH, Scadding GK. Chronic rhinosinusitis: therapeutic efficacy of anti-inflammatory and antibiotic approaches. Allergy Asthma Immunol Res. 2011;3(4):226–35. https://doi.org/10.4168/aair.2011.3.4.226.CrossRefPubMedPubMedCentral

68.

Nussbaum EL, Lilge L, Mazzulli T. Effects of low-level laser therapy (LLLT) of 810 nm upon in vitro growth of bacteria: relevance of irradiance and radiant exposure. J Clin Laser Med Surg. 2003;21(5):283–90. https://doi.org/10.1089/104454703322564497.CrossRefPubMed

69.

Omar GS, Wilson M, Nair SP. Lethal photosensitization of wound-associated microbes using indocyanine green and near-infrared light. BMC Microbiol. 2008;8:111. https://doi.org/10.1186/1471-2180-8-111.CrossRefPubMedPubMedCentral

70.

Tuchin VV, Genina EA, Bashkatov AN, Simonenko GV, Odoevskaya OD, Altshuler GB. A pilot study of ICG laser therapy of acne vulgaris: photodynamic and photothermolysis treatment. Lasers Surg Med. 2003;33(5):296–310. https://doi.org/10.1002/lsm.10211.CrossRefPubMed

71.

Krespi YP, Kizhner V. Phototherapy for chronic rhinosinusitis. Lasers Surg Med. 2011;43(3):187–91. https://doi.org/10.1002/lsm.21042.CrossRefPubMed

72.

Nikolic-Paterson DJ, Atkins RC. The role of macrophages in glomerulonephritis. Nephrol Dial Transplant. 2001;16(Suppl 5):3–7.CrossRef

73.

Takemura T, Yoshioka K, Murakami K, Akano N, Okada M, Aya N, et al. Cellular localization of inflammatory cytokines in human glomerulonephritis. Virchows Arch. 1994;424(5):459–64.CrossRef

74.

Bremer V, Tojo A, Kimura K, Hirata Y, Goto A, Nagamatsu T, et al. Role of nitric oxide in rat nephrotoxic nephritis: comparison between inducible and constitutive nitric oxide synthase. J Am Soc Nephrol. 1997;8(11):1712–21.PubMed

75.

Tesch GH, Yang N, Yu H, Lan HY, Foti R, Chadban SJ, et al. Intrinsic renal cells are the major source of interleukin-1 beta synthesis in normal and diseased rat kidney. Nephrol Dial Transplant. 1997;12(6):1109–15.CrossRef

76.

Yamato M, Kaneda A, Kataoka Y. Low-level laser therapy improves crescentic glomerulonephritis in rats. Lasers Med Sci. 2013;28(4):1189–96. https://doi.org/10.1007/s10103-012-1229-6.CrossRefPubMed

77.

Sospedra M, Martin R. Immunology of multiple sclerosis. Semin Neurol. 2016;36(2):115–27. https://doi.org/10.1055/s-0036-1579739.CrossRefPubMed

78.

Oron A, Oron U, Chen J, Eilam A, Zhang C, Sadeh M, et al. Low-level laser therapy applied transcranially to rats after induction of stroke significantly reduces long-term neurological deficits. Stroke. 2006;37(10):2620–4. https://doi.org/10.1161/01.STR.0000242775.14642.b8.CrossRefPubMed

79.

Xuan W, Vatansever F, Huang L, Wu Q, Xuan Y, Dai T, et al. Transcranial low-level laser therapy improves neurological performance in traumatic brain injury in mice: effect of treatment repetition regimen. PLoS One. 2013;8(1):e53454. https://doi.org/10.1371/journal.pone.0053454.CrossRefPubMedPubMedCentral

80.

Oron A, Oron U, Streeter J, De Taboada L, Alexandrovich A, Trembovler V, et al. Near infrared transcranial laser therapy applied at various modes to mice following traumatic brain injury significantly reduces long-term neurological deficits. J Neurotrauma. 2012;29(2):401–7. https://doi.org/10.1089/neu.2011.2062.CrossRefPubMed

81.

Farfara D, Tuby H, Trudler D, Doron-Mandel E, Maltz L, Vassar RJ, et al. Low-level laser therapy ameliorates disease progression in a mouse model of Alzheimer’s disease. J Mol Neurosci. 2015;55(2):430–6. https://doi.org/10.1007/s12031-014-0354-z.CrossRefPubMed

82.

De Taboada L, Yu J, El-Amouri S, Gattoni-Celli S, Richieri S, McCarthy T, et al. Transcranial laser therapy attenuates amyloid-beta peptide neuropathology in amyloid-beta protein precursor transgenic mice. J Alzheimers Dis. 2011;23(3):521–35. https://doi.org/10.3233/JAD-2010-100894.CrossRefPubMed

83.

Goncalves ED, Souza PS, Lieberknecht V, Fidelis GS, Barbosa RI, Silveira PC, et al. Low-level laser therapy ameliorates disease progression in a mouse model of multiple sclerosis. Autoimmunity. 2016;49(2):132–42. https://doi.org/10.3109/08916934.2015.1124425.CrossRefPubMed

84.

Rothers J, Halonen M, Stern DA, Lohman IC, Mobley S, Spangenberg A, et al. Adaptive cytokine production in early life differentially predicts total IgE levels and asthma through age 5 years. J Allergy Clin Immunol. 2011;128(2):397–402 e2. https://doi.org/10.1016/j.jaci.2011.04.044.CrossRefPubMedPubMedCentral

85.

Dubois A, Deruytter N, Adams B, Kanda A, Delbauve S, Fleury S, et al. Regulation of Th2 responses and allergic inflammation through bystander activation of CD8+ T lymphocytes in early life. J Immunol. 2010;185(2):884–91. https://doi.org/10.4049/jimmunol.0903287.CrossRefPubMed

86.

Luzina IG, Lockatell V, Lavania S, Pickering EM, Kang PH, Bashkatova YN, et al. Natural production and functional effects of alternatively spliced interleukin-4 protein in asthma. Cytokine. 2012;58(1):20–6. https://doi.org/10.1016/j.cyto.2011.12.017.CrossRefPubMedPubMedCentral

87.

Basu K, Nair A, Williamson PA, Mukhopadhyay S, Lipworth BJ. Airway and systemic effects of soluble and suspension formulations of nebulized budesonide in asthmatic children. Ann Allergy Asthma Immunol. 2009;103(5):436–41. https://doi.org/10.1016/S1081-1206(10)60365-1.CrossRefPubMed

88.

Wang XY, Ma WJ, Liu CS, Li YX. Effect of low-level laser therapy on allergic asthma in rats. Lasers Med Sci. 2014;29(3):1043–50. https://doi.org/10.1007/s10103-013-1456-5.CrossRefPubMed

89.

Barnes PJ. Mechanisms and resistance in glucocorticoid control of inflammation. J Steroid Biochem Mol Biol. 2010;120(2–3):76–85. https://doi.org/10.1016/j.jsbmb.2010.02.018.CrossRefPubMed

90.

Souza NH, Marcondes PT, Albertini R, Mesquita-Ferrari RA, Fernandes KP, Aimbire F. Low-level laser therapy suppresses the oxidative stress-induced glucocorticoids resistance in U937 cells: relevance to cytokine secretion and histone deacetylase in alveolar macrophages. J Photochem Photobiol B. 2014;130:327–36. https://doi.org/10.1016/j.jphotobiol.2013.12.010.CrossRefPubMed

91.

Shirasu N, Nam SO, Kuroki M. Tumor-targeted photodynamic therapy. Anticancer Res. 2013;33(7):2823–31.PubMed

92.

Perez-Laguna V, Gilaberte Y, Millan-Lou MI, Agut M, Nonell S, Rezusta A, et al. A combination of photodynamic therapy and antimicrobial compounds to treat skin and mucosal infections: a systematic review. Photochem Photobiol Sci. 2019;18(5):1020–9. https://doi.org/10.1039/c8pp00534f.CrossRefPubMed

93.

Huang L, Xuan W, Sarna T, Hamblin MR. Comparison of thiocyanate and selenocyanate for potentiation of antimicrobial photodynamic therapy. J Biophotonics. 2019;12(1):e201800092. https://doi.org/10.1002/jbio.201800092.CrossRefPubMed

94.

Fan L, Yin R, Lan T, Hamblin MR. Photodynamic therapy for rosacea in Chinese patients. Photodiagn Photodyn Ther. 2018;24:82–7. https://doi.org/10.1016/j.pdpdt.2018.08.005.CrossRef

95.

Shamay Y, Adar L, Ashkenasy G, David A. Light induced drug delivery into cancer cells. Biomaterials. 2011;32(5):1377–86. https://doi.org/10.1016/j.biomaterials.2010.10.029.CrossRefPubMed

96.

Thompson S, Self AC, Self CH. Light-activated antibodies in the fight against primary and metastatic cancer. Drug Discov Today. 2010;15(11–12):468–73. https://doi.org/10.1016/j.drudis.2010.04.006.CrossRefPubMed

97.

Yavlovich A, Smith B, Gupta K, Blumenthal R, Puri A. Light-sensitive lipid-based nanoparticles for drug delivery: design principles and future considerations for biological applications. Mol Membr Biol. 2010;27(7):364–81. https://doi.org/10.3109/09687688.2010.507788.CrossRefPubMedPubMedCentral

98.

Strangman GE, Zhang Q, Li Z. Scalp and skull influence on near infrared photon propagation in the Colin27 brain template. Neuroimage. 2014;85(Pt 1):136–49. https://doi.org/10.1016/j.neuroimage.2013.04.090.CrossRefPubMed

99.

Haeussinger FB, Heinzel S, Hahn T, Schecklmann M, Ehlis AC, Fallgatter AJ. Simulation of near-infrared light absorption considering individual head and prefrontal cortex anatomy: implications for optical neuroimaging. PLoS One. 2011;6(10):e26377. https://doi.org/10.1371/journal.pone.0026377.CrossRefPubMedPubMedCentral

100.

Okada E, Delpy DT. Near-infrared light propagation in an adult head model. I. Modeling of low-level scattering in the cerebrospinal fluid layer. Appl Opt. 2003;42(16):2906–14.CrossRef

101.

Jagdeo JR, Adams LE, Brody NI, Siegel DM. Transcranial red and near infrared light transmission in a cadaveric model. PLoS One. 2012;7(10):e47460. https://doi.org/10.1371/journal.pone.0047460.CrossRefPubMedPubMedCentral

102.

Tedford CE, DeLapp S, Jacques S, Anders J. Quantitative analysis of transcranial and intraparenchymal light penetration in human cadaver brain tissue. Lasers Surg Med. 2015;47(4):312–22. https://doi.org/10.1002/lsm.22343.CrossRefPubMed

103.

Lapchak PA, Boitano PD, Butte PV, Fisher DJ, Holscher T, Ley EJ, et al. Transcranial near-infrared laser transmission (NILT) profiles (800 nm): systematic comparison in four common research species. PLoS One. 2015;10(6):e0127580. https://doi.org/10.1371/journal.pone.0127580.CrossRefPubMedPubMedCentral

104.

Pitzschke A, Lovisa B, Seydoux O, Zellweger M, Pfleiderer M, Tardy Y, et al. Red and NIR light dosimetry in the human deep brain. Phys Med Biol. 2015;60(7):2921–37. https://doi.org/10.1088/0031-9155/60/7/2921.CrossRefPubMed

105.

Henderson TA, Morries LD. Near-infrared photonic energy penetration: can infrared phototherapy effectively reach the human brain? Neuropsychiatr Dis Treat. 2015;11:2191–208. https://doi.org/10.2147/NDT.S78182.CrossRefPubMedPubMedCentral

106.

Shell TA, Shell JR, Rodgers ZL, Lawrence DS. Tunable visible and near-IR photoactivation of light-responsive compounds by using fluorophores as light-capturing antennas. Angew Chem Int Ed Engl. 2014;53(3):875–8. https://doi.org/10.1002/anie.201308816.CrossRefPubMed

107.

Shell TA, Lawrence DS. Vitamin B12: a tunable, long wavelength, light-responsive platform for launching therapeutic agents. Acc Chem Res. 2015;48(11):2866–74. https://doi.org/10.1021/acs.accounts.5b00331.CrossRefPubMedPubMedCentral

108.

Issa JPM, Trawitzki BF, Ervolino E, Macedo AP, Lilge L. Low-intensity laser therapy efficacy evaluation in FVB mice subjected to acute and chronic arthritis. Lasers Med Sci. 2017;32(6):1269–77. https://doi.org/10.1007/s10103-017-2235-5.CrossRefPubMed

109.

Naghdi S, Ansari NN, Fathali M, Bartley J, Varedi M, Honarpishe R. A pilot study into the effect of low-level laser therapy in patients with chronic rhinosinusitis. Physiother Theory Pract. 2013;29(8):596–603. https://doi.org/10.3109/09593985.2013.775204.CrossRefPubMed

110.

Silva VR, Marcondes P, Silva M, Villaverde AB, Castro-Faria-Neto HC, Vieira RP, et al. Low-level laser therapy inhibits bronchoconstriction, Th2 inflammation and airway remodeling in allergic asthma. Respir Physiol Neurobiol. 2014;194:37–48. https://doi.org/10.1016/j.resp.2014.01.008.CrossRefPubMed

Titel: Laser Light Therapy in Inflammatory, Musculoskeletal, and Autoimmune Disease
verfasst von: Victoria A. Wickenheisser
Emilia Marta Zywot
Emily Mary Rabjohns
Hyun Ho Lee
David S. Lawrence
Teresa Kathleen Tarrant
Publikationsdatum: 01.08.2019
Verlag: Springer US
Erschienen in: Current Allergy and Asthma Reports / Ausgabe 8/2019
Print ISSN: 1529-7322
Elektronische ISSN: 1534-6315
DOI: https://doi.org/10.1007/s11882-019-0869-z

Neu im Fachgebiet HNO

16.04.2024 | HNO-Chirurgie | Nachrichten

Update HNO

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert – ganz bequem per eMail.

Newsletter bestellen

Springer Medizin

Laser Light Therapy in Inflammatory, Musculoskeletal, and Autoimmune Disease

Abstract

Purpose of Review

Recent Findings

Summary

Neu im Fachgebiet HNO

HNO-Op. auch mit über 90?

Intrakapsuläre Tonsillektomie gewinnt an Boden

Bilateraler Hörsturz hat eine schlechte Prognose

„Nur wer sich gut aufgehoben fühlt, kann auch für Patientensicherheit sorgen“

Update HNO

Springer Medizin

Abstract

Purpose of Review

Recent Findings

Summary

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Neu im Fachgebiet HNO

HNO-Op. auch mit über 90?

Intrakapsuläre Tonsillektomie gewinnt an Boden

Bilateraler Hörsturz hat eine schlechte Prognose

„Nur wer sich gut aufgehoben fühlt, kann auch für Patientensicherheit sorgen“

Update HNO